Title: Data Analysis as part of the Assessment Process
1Data Analysis as part of the Assessment Process
- Jill Burke
- Insight Solutions
2Who are we?
- Established since 2001
- Independent IT training consultancy
- Not affiliated to any of the clinical suppliers
- Designated Clinical System trainers for all major
systems - Working with 2500 practices
- Working in over 75 PCOs/LHBs
- Accredited training Company
- main contract software suppliers
- Welsh Assembly Government
- nGMS Contract Training specialists
- IT Training Specialists for Primary Care
3Ethical Disclaimer
- All information provided during this presentation
is an opinion and is, therefore, optional. It is
designed to enhance your abilities to work with
the nGMS Contract should you wish - It is based on how QoF 2 stands today! There are
likely to be many changes, it is the
responsibility of the practice to ensure they
keep up-to-date with any future changes made - The decision to implement any changes rest
entirely with each practice/clinician
4Why?
- Assessments in the past have often been routine
- Assessors going through learning curve
- Practices expecting you to look at patient data
for evidence - Largest investment in Primary Care
- Practice income higher than ever before
5Where are we now?
- QoF2
- Established a process of assessing
- Identified a need to move this forward
- 2 years of back data and information from QoF
- years of other information
- Prescribing data
- Prevalence
- 2 years experience of assessing
- But not necessarily using all the information
together
6Where do we want to be?
- Assessing practices
- Accurately, consistently and relevantly
- Justifying payments
- Confident practice have achieved as a result of
hard work - Not just ticking boxes
7Benefits outside of QoF?
- Chronic Disease management
- Powerful information for commissioning of
services - Community Matrons
- Admissions Prevention
- Practice Based Commissioning
- Accurate Disease Prevalence
- Budget Setting
- Better Patient Services
- Patient Pathways
8Data AnalysisA new dimension
9Three Approaches
- Comparing expected and observed prevalence rates
- Identifying high levels of exception reporting
- Comparing prescribing and prevalence rates
- Approaches will identify lines of enquiry not
definitive answer to questions of gaming - Making assessments worthwhile
101. Prevalence Rates
- QMAS reports crude prevalence rates not
adjusted for risk factors (age, sex ethnicity
etc) - Very high / low rates might be explained by these
factors - Doncaster PCT have generated a tool that refines
expected prevalence rates for 7 conditions based
on practice level socio-demographic factors
11Data required
- Practice Level
- Reported prevalence rates (QMAS)
- Age sex breakdown
- Deprivation
- PCT will need to data entry into spreadsheet
time consuming but worthwhile results
12Model Output
13(No Transcript)
14(No Transcript)
152.Exception Reporting
- Exception reporting codes concerns
- over-use
- under use
- misuse
- Comparison can be made with reference to PCT
average level of exception reporting and size of
disease register - QMAS provides data on levels of exception
reporting
16Automatically identifies indicators where the
practice varies from PCT average
17Locate data in QMAS
18Download into Spreadsheet
19A few simple calculations
20Produce Control Chart
21(No Transcript)
223. Comparing Prescribing and Prevalence Rates
- One would expect strong association between
prevalence rates and prescribing rates for
chronic diseases - Variance from expected might indicate inaccurate
registers - School of Medicines Management (Keele Uni) have
investigated this approach
23CHD Register Size vs Chapter 2 Prescribing
EXAMPLE
24CHD Register Size vs Chapter 2 Prescribing
Poor Data Quality? Patients not identified on
Registers
Poor Data Quality Inflated registers?
25Practice to benefit
- If prevalence is high and incorrect, practice
targeted to deliver services to patients who not
in need - More work
- Less success
- Fewer points
- If prevalence is low and incorrect , practice may
be doing the work but not getting recognition - Less per point
26Patient to Benefit
- Correct services offered to relevant patients
- Patient care to improve
- Practices dont waste patients time
27PCT to Benefit
- Correct investment of public money
- Patient services improved
- Practice achievement improves
28Other possible checks
- Hypertension prevalence vs anti-hypertensive
prescribing - BP5 vs anti-hypertensive large amount of points
- Asthma and COPD prevalence vs BNF Chapter 3
prescribing - Diabetes prevalence vs diabetic prescribing
- Epilepsy prevalence vs anti-epileptic prescribing
- CHD8 compared with lipid lowering prescribing
29What to target
- With so many areas / indicators / disease
registers be selective - Identify which registers / indicators are best
for target - High points potentially expensive for PCTs if
there is concern - Speciality within practice/PCT
- Diabetes
- Asthma etc.
Use data analysis to establish this
30High Point Indicators
- CHD5 BP less that 150/90 - 19
- CHD8 Cholesterol less than 5 - 17
- BP4 BP recorded in past 9 months - 20
- BP5 BP less than 150/90 - 57
- DM20 HbA1c 7.5 or less - 17
- MH9 review in past yr - 23
- Asthma3 variability/reversibility - 15
- Asthma6 review - 20
- DEM2 review - 15
- DEP2 assessment - 25
- AF3 anticoagulation/platelet - 15
- Smoking - 68
31Best use of data
- Pointless to have all this data and use it in
isolation - Cross referencing all sources
- E.g. Prescribing versus prevalence
- Prescribing versus achievement
- Exception reporting versus Prevalence
- Practice to practice comparisons
32Summary
- Data will need to be collected, prepared,
analysed and understood before the assessment - Assessors should have the questions ready to ask
- May need practice input for some data
- Standard approach across PCT for all practices
- Target areas pre defined
- Training if required
- Assessors need to see the benefit
- May require specific training e.g. Excel